Latest Strategy Changes News

Page 333 of 1117
Alexium International Group reported a 26% rise in Q1 FY26 sales driven by new business wins and expanded foam bedding applications, while navigating tighter funding conditions.
Victor Sage
Victor Sage
31 Oct 2025
PhosCo Ltd reports breakthrough drilling results at its Gasaat Phosphate Project in Tunisia, securing a €1M grant from EBRD and a $1.1M investment from its Managing Director, setting the stage for a pivotal feasibility study.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Constellation Technologies reports solid first-quarter progress driven by strong demand for its Callisto Food Safety System and new handheld temperature device, alongside promising integration projects and steady revenue.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Victory Metals has significantly upgraded its North Stanmore rare earths resource, reporting record dysprosium grades and producing a high-purity rare earth oxide. The company also secured strategic partnerships and $11.5 million in new funding.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Elevate Uranium has raised $25 million through a well-supported placement, boosting its cash reserves to nearly $44 million. The funds will accelerate its proprietary U-pgrade™ pilot plant and expand uranium resource drilling in Namibia and Australia.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Enlitic, Inc. reported a strong quarter with record cash receipts and contract wins, yet withdrew its revenue guidance due to delayed project completions. The company remains confident in reaching operational cash flow break-even by the end of Q4 FY25.
Victor Sage
Victor Sage
31 Oct 2025
Artrya Limited has completed the second tranche of its share placement, raising $14.7 million to advance its AI-powered Salix platform for coronary artery disease detection.
Ada Torres
Ada Torres
31 Oct 2025
Central Petroleum reported a slight dip in sales volumes and revenue for the September quarter, offset by a significant reserves upgrade and a new long-term gas supply agreement that promises cash flow stability.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.
Ada Torres
Ada Torres
31 Oct 2025
Codeifai Limited reports a 10% revenue increase in Q3 2025 and completes due diligence on the QuantumAI Secure platform acquisition, signaling a strategic pivot into quantum-resilient fintech solutions.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Apollo Minerals reports encouraging exploration results from its Gabon projects, highlighting significant gold intercepts at Salanie and a substantial zinc-lead target at Kroussou, while navigating funding constraints and ongoing legal challenges in Europe.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Cooper Metals is gearing up for drilling at its Mt Isa East copper-gold project while divesting a majority stake in its Gilberton Gold Project to Sybella Metals, maintaining a solid cash position to fund exploration.
Maxwell Dee
Maxwell Dee
31 Oct 2025